$46.78 $0.03 (0.1%)

04:00 PM EST on 11/22/19

RA Pharmaceuticals (NASDAQ:RARX)

CAPS Rating: No stars

Current Price $46.78 Mkt Cap $2.2B
Open $46.91 P/E Ratio 0.00
Prev. Close $46.75 Div. (Yield) $0.00 (0.0%)
Daily Range $46.74 - $46.91 Volume 497,148
52-Wk Range $17.48 - $47.35 Avg. Daily Vol. 1,446,112

Caps

How do you think NASDAQ:RARX will perform against the market?

Add Stock to CAPS Watchlist

All Players

5 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:RARX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:RARX VS S&P 500 (SPY)

NASDAQ:RARX Summary

Fools bullish on NASDAQ:RARX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about RARX.

No one has written a Pitch for RARX stock yet. Tell us why you think RARX will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in RARX.

Score Leader

stainsolution

stainsolution (< 20) Score: +463.55

The Score Leader is the player with the highest score across all their picks in RARX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
stainsolution < 20 1/19/2018 Outperform 5Y $8.14 +474.69% +11.14% +463.55 0 Comment
jeepdrew222 60.91 12/22/2017 Outperform 5Y $8.35 +460.15% +16.38% +443.77 0 Comment
DavidLBack 77.55 7/30/2018 Outperform 3Y $11.07 +322.58% +10.84% +311.74 0 Comment
shonny2 < 20 1/8/2019 Outperform 5Y $21.92 +113.46% +21.86% +91.60 0 Comment
jcder 23.48 7/26/2019 Outperform 5Y $34.25 +36.58% +3.40% +33.19 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RARX.